Is the FDA too conservative or too aggressive?: a Bayesian decision analysis of clinical trial design (Q2000854)
From MaRDI portal
 | This is the item page for this Wikibase entity, intended for internal use and editing purposes. Please use this page instead for the normal view: Is the FDA too conservative or too aggressive?: a Bayesian decision analysis of clinical trial design |
scientific article; zbMATH DE number 7075171
| Language | Label | Description | Also known as |
|---|---|---|---|
| default for all languages | No label defined |
||
| English | Is the FDA too conservative or too aggressive?: a Bayesian decision analysis of clinical trial design |
scientific article; zbMATH DE number 7075171 |
Statements
Is the FDA too conservative or too aggressive?: a Bayesian decision analysis of clinical trial design (English)
0 references
1 July 2019
0 references
clinical trial design
0 references
drug-approval process
0 references
FDA
0 references
Bayesian decision analysis
0 references
adaptive design
0 references
0.7600818276405334
0 references
0.7448439002037048
0 references
0.739037275314331
0 references
